Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Hormones02:13

Types of Hormones

83.2K
Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
83.2K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

5.3K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.3K
Plant Hormones01:56

Plant Hormones

27.4K
Plant hormones—or phytohormones—are chemical molecules that modulate one or more physiological processes of a plant. In animals, hormones are often produced in specific glands and circulated via the circulatory system. However, plants lack hormone-producing glands.
27.4K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

711
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
711
Hormonal Regulation01:33

Hormonal Regulation

35.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.8K
Hormonal Regulation01:40

Hormonal Regulation

47.9K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
47.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Soluble Antigen Arrays Alter the Response of Epitope-Specific Diabetogenic T Cells.

ACS applied bio materials·2026
Same author

Engineered Nonhormonal, Cationic Proinsulin Variants Prolong Lymphatic Drainage.

Molecular pharmaceutics·2025
Same author

Impact of Hydrophobic, Hydrophilic, and Mucus-Binding Motifs on the Therapeutic Potential of Ceftazidime Analogs for Pulmonary Administration.

Antibiotics (Basel, Switzerland)·2025
Same author

Glatiramer Acetate Complexes CpG Oligodeoxynucleotides into Nanoparticles and Boosts Their TLR9-Driven Immunity.

Molecular pharmaceutics·2024
Same author

Cytotoxicity of Doxorubicin-Curcumin Nanoparticles Conjugated with Two Different Peptides (CKR and EVQ) against FLT3 Protein in Leukemic Stem Cells.

Polymers·2024
Same author

Optimized Production of Fc Fusion Proteins by Sortase Enzymatic Ligation.

Industrial & engineering chemistry research·2024

相关实验视频

Updated: Jan 24, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

19.2K

可溶性抗原阵列显示亲胰岛素 (F25D) 选择性向抗胰岛素B细胞,没有荷尔蒙影响.

Grant M Downes1, Kyle D Apley2, Gang Hu3

  • 1Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas 66045, United States.

Molecular pharmaceutics
|January 23, 2026
PubMed
概括

一种针对突变型亲胰岛素 (M-PI(F25D)) 的新型可溶性抗原阵列 (SAgA) 显示出对1型糖尿病 (T1D) 抗原特异性免疫疗法 (ASIT) 的希望. 这种方法避免了血糖的影响,同时专门针对自身反应性B细胞和抗胰岛素抗体.

关键词:
1 型糖尿病 1 型糖尿病抗胰岛素的B细胞.抗原特异性免疫疗法 抗原特异性免疫疗法氨酸 - 蛋白质结合物 氨酸-蛋白质结合物非激素的亲胰岛素可溶性抗原阵列的溶性抗原阵列

更多相关视频

Spore Adsorption as a Nonrecombinant Display System for Enzymes and Antigens
07:42

Spore Adsorption as a Nonrecombinant Display System for Enzymes and Antigens

Published on: March 19, 2019

7.1K
The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo
12:09

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo

Published on: June 19, 2014

14.9K

相关实验视频

Last Updated: Jan 24, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

19.2K
Spore Adsorption as a Nonrecombinant Display System for Enzymes and Antigens
07:42

Spore Adsorption as a Nonrecombinant Display System for Enzymes and Antigens

Published on: March 19, 2019

7.1K
The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo
12:09

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo

Published on: June 19, 2014

14.9K

科学领域:

  • 免疫学 免疫学 免疫学
  • 内分泌学 在内分泌学.
  • 生物技术是生物技术.

背景情况:

  • 1型糖尿病 (T1D) 的发病包括由胰腺小岛上的树突细胞和B淋巴细胞向自身反应的T细胞呈现抗原.
  • 目前的免疫抑制疗法如rituximab和teplizumab携带因B或T细胞枯竭而导致感染的风险.
  • 抗原特异性免疫疗法 (ASIT) 提供了一种有针对性的方法来抑制或删除自身反应细胞.

研究的目的:

  • 开发一种新的可溶性抗原阵列 (SAgA) 平台,用于T1D干预.
  • 创建一个突变的亲胰岛素抗原 (亲胰岛素 (F25D)) 与氨酸 (HA) 骨干 (SAgA) 结合,保留了疾病向能力而没有血糖活性.
  • 评估SAgAM-PI(F25D)在向自身反应性B细胞和抗胰岛素抗体方面的特异性和有效性.

主要方法:

  • 突变的益胰岛素 (益胰岛素 (F25D)) 与氨酸 (HA) 骨干的结合,形成SAgA.
  • 评估胰岛素受体β活性和体内血糖影响.
  • 用与疾病相关的单克隆抗胰岛素抗体和对人类胰岛素特异的 murine 转基因 (Tg125) B 细胞进行结合性测试.

主要成果:

  • SAgAM-PI(F25D)显示胰岛素受体β活性明显降低.
  • 开发的SAgA缺乏显著的血糖活性in vivo.
  • SAgAM-PI(F25D)对一种与疾病相关的单克隆抗胰岛素抗体表现出较低的纳米分子结合亲和力,并特别结合于小鼠转基因 (Tg125) B 细胞.

结论:

  • 突变的亲胰岛素SAgA (SAgAM-PI(F25D)有效地避免了血糖影响,同时保持了对抗胰岛素抗体和与胰岛素结合的B细胞的特异性.
  • 这种SAgA平台代表了1型糖尿病抗原特异性免疫治疗的有希望的候选人.
  • SAgAM-PI(F25D)的有针对性的方法为T1D的更广泛的免疫抑制疗法提供了潜在的替代方案.